# Analysis of the Efficacy of Cardiac Ischemic Postconditioning With New Clinical End-points Using Novel Biomarkers

Study · id `cardio:ct-nct04824716` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04824716](<https://clinicaltrials.gov/study/NCT04824716>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04824716

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT04824716. Randomized; single masking; primary purpose basic science. Start 2013-01-14 (actual); primary completion 2018-10-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose basic science
- Phase: Not applicable
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT04824716, source copy `cardio:ctgov-nct04824716-2021-04-21`, retrieved 2026-10-26)
- Started: 2013-01-14 (actual) (ClinicalTrials.gov record NCT04824716, source copy `cardio:ctgov-nct04824716-2021-04-21`, retrieved 2026-10-26)
- Primary completion: 2018-10-15 (actual) (ClinicalTrials.gov record NCT04824716, source copy `cardio:ctgov-nct04824716-2021-04-21`, retrieved 2026-10-26)
- Completion: 2018-10-15 (actual) (ClinicalTrials.gov record NCT04824716, source copy `cardio:ctgov-nct04824716-2021-04-21`, retrieved 2026-10-26)
- Countries: Hungary (ClinicalTrials.gov record NCT04824716, source copy `cardio:ctgov-nct04824716-2021-04-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04824716-2021-04-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Analysis of the Efficacy of Cardiac Ischemic Postconditioning With New Clinical End-points Using Novel Biomarkers
- Condition: Acute Myocardial Infarction With ST Elevation
- Intervention (Procedure): Postconditioning
- Intervention (Device): Percutaneous coronary intervention
- Lead sponsor: Peter Ferdinandy
- Lead sponsor class: INDUSTRY
- Collaborator: Semmelweis University Heart and Vascular Center
- Collaborator class: OTHER
- Collaborator: Szeged University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as a collaborator: Semmelweis University Heart and Vascular Center (`cardio:org-semmelweis-university-heart-and-vascular-center`)

## Provenance

Content hash: 4ee542870aa88608caf5ab1e0802f063be8cce63190ecb972582e038d509454a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
